| Product Code: ETC10768462 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Percutaneotranshepatic Cholangiography Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Percutaneotranshepatic Cholangiography Market - Industry Life Cycle |
3.4 Canada Percutaneotranshepatic Cholangiography Market - Porter's Five Forces |
3.5 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume Share, By Procedure Type, 2021 & 2031F |
3.6 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume Share, By Guidance Technique, 2021 & 2031F |
3.8 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume Share, By Imaging Type, 2021 & 2031F |
4 Canada Percutaneotranshepatic Cholangiography Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of liver diseases in Canada |
4.2.2 Technological advancements in percutaneous transhepatic cholangiography procedures |
4.2.3 Growing adoption of minimally invasive procedures in healthcare |
4.3 Market Restraints |
4.3.1 High cost associated with percutaneous transhepatic cholangiography procedures |
4.3.2 Limited awareness about the benefits of percutaneous transhepatic cholangiography among patients and healthcare providers |
5 Canada Percutaneotranshepatic Cholangiography Market Trends |
6 Canada Percutaneotranshepatic Cholangiography Market, By Types |
6.1 Canada Percutaneotranshepatic Cholangiography Market, By Procedure Type |
6.1.1 Overview and Analysis |
6.1.2 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Procedure Type, 2021 - 2031F |
6.1.3 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Diagnostic PTC, 2021 - 2031F |
6.1.4 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Therapeutic PTC, 2021 - 2031F |
6.1.5 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Percutaneous Transhepatic Biliary Drainage, 2021 - 2031F |
6.1.6 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Stent Placement, 2021 - 2031F |
6.1.7 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Biopsy-Guided PTC, 2021 - 2031F |
6.2 Canada Percutaneotranshepatic Cholangiography Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Biliary Obstruction, 2021 - 2031F |
6.2.3 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Bile Duct Strictures, 2021 - 2031F |
6.2.4 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Cholangiocarcinoma, 2021 - 2031F |
6.2.5 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Gallstone Removal, 2021 - 2031F |
6.2.6 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Liver Disease Diagnosis, 2021 - 2031F |
6.3 Canada Percutaneotranshepatic Cholangiography Market, By Guidance Technique |
6.3.1 Overview and Analysis |
6.3.2 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Ultrasound-Guided, 2021 - 2031F |
6.3.3 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Fluoroscopy-Guided, 2021 - 2031F |
6.3.4 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By MRI-Guided, 2021 - 2031F |
6.3.5 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Endoscopy-Guided, 2021 - 2031F |
6.3.6 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Hybrid-Guided, 2021 - 2031F |
6.4 Canada Percutaneotranshepatic Cholangiography Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.4 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.4.5 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
6.4.6 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Ambulatory Care, 2021 - 2031F |
6.5 Canada Percutaneotranshepatic Cholangiography Market, By Imaging Type |
6.5.1 Overview and Analysis |
6.5.2 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By X-ray Imaging, 2021 - 2031F |
6.5.3 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By CT Imaging, 2021 - 2031F |
6.5.4 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Contrast-Enhanced Imaging, 2021 - 2031F |
6.5.5 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Digital Imaging, 2021 - 2031F |
6.5.6 Canada Percutaneotranshepatic Cholangiography Market Revenues & Volume, By Advanced 3D Imaging, 2021 - 2031F |
7 Canada Percutaneotranshepatic Cholangiography Market Import-Export Trade Statistics |
7.1 Canada Percutaneotranshepatic Cholangiography Market Export to Major Countries |
7.2 Canada Percutaneotranshepatic Cholangiography Market Imports from Major Countries |
8 Canada Percutaneotranshepatic Cholangiography Market Key Performance Indicators |
8.1 Average waiting time for percutaneous transhepatic cholangiography procedures |
8.2 Number of healthcare facilities offering percutaneous transhepatic cholangiography services |
8.3 Patient satisfaction rate with percutaneous transhepatic cholangiography procedures |
8.4 Percentage of healthcare providers trained in performing percutaneous transhepatic cholangiography |
8.5 Rate of complications associated with percutaneous transhepatic cholangiography procedures |
9 Canada Percutaneotranshepatic Cholangiography Market - Opportunity Assessment |
9.1 Canada Percutaneotranshepatic Cholangiography Market Opportunity Assessment, By Procedure Type, 2021 & 2031F |
9.2 Canada Percutaneotranshepatic Cholangiography Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Canada Percutaneotranshepatic Cholangiography Market Opportunity Assessment, By Guidance Technique, 2021 & 2031F |
9.4 Canada Percutaneotranshepatic Cholangiography Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Canada Percutaneotranshepatic Cholangiography Market Opportunity Assessment, By Imaging Type, 2021 & 2031F |
10 Canada Percutaneotranshepatic Cholangiography Market - Competitive Landscape |
10.1 Canada Percutaneotranshepatic Cholangiography Market Revenue Share, By Companies, 2024 |
10.2 Canada Percutaneotranshepatic Cholangiography Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here